WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-544 Cr | ₹-576 Cr | ₹-545 Cr | ₹-370 Cr | ₹-398 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WOCKHARDT ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-544 Cr |
Mar2023 | ₹-576 Cr |
Mar2022 | ₹-545 Cr |
Mar2021 | ₹-370 Cr |
Mar2020 | ₹-398 Cr |
How is Deferred Tax Assets / Liabilities of WOCKHARDT Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-544 Cr | Negative | |
Mar2023 | ₹-576 Cr | Negative | |
Mar2022 | ₹-545 Cr | Negative | |
Mar2021 | ₹-370 Cr | Negative | |
Mar2020 | ₹-398 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹22,223.5 Cr | -11.2% | -5.1% | 195.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -11.2% |
-5.1% |
195.5% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses